Equity Research, Broker Reports, and media content on Oncimmune Holdings Plc

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Oncimmune Holdings Plc
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Oncimmune Holdings Plc

Company Profile

  • Personnel
  • Adam Hill, CEO
  • Matthew Hall, CFO

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Oncimmune Holdings Plc. We currently have 93 research reports from 7 professional analysts.

  • Open: N/A
  • Range Today: N/A
  • 52 Week: 151/262p
  • Daily Volume: N/A
  • Daily Liquidity: (0.06%)
  • # Shares: 69.1m
  • Market Cap: £124.4m
  • Latest PE (hist):
  • Div Yield:
Date Source Announcement
20Sep21 07:00 RNS Oncimmune Hldngs PLC - Agreement with pharma company to profile patients
15Sep21 11:08 RNS Oncimmune Hldngs PLC - Block Listing Six Monthly Return
23Aug21 07:00 RNS Oncimmune Hldngs PLC - Three-year follow-up data for the ECLS trial
23Jul21 07:00 RNS Oncimmune Hldngs PLC - Agreement signed with major cancer center
22Jul21 07:00 RNS Oncimmune Hldngs PLC - Validation of ImmunoINSIGHTS service in COVID-19
01Jul21 07:00 RNS Oncimmune Hldngs PLC - Total Voting Rights
08Jun21 07:00 RNS Oncimmune Hldngs PLC - Full Year Trading Update
  • Frequency of research reports

     

  • Research reports on

    Oncimmune Holdings Plc

  • Providers covering

    Oncimmune Holdings Plc